netFormulary NHS
Birmingham, Sandwell, Solihull and environs APC Formulary
Maintained by Midlands and Lancashire Commissioning Support Unit
 Formulary Chapter 14: Immunological products and vaccines - Full Chapter

Products will be prescribed and used in accordance with the guidance from the Department of Health handbook “Immunisation against infectious diseases” i.e. the Green Book and specialised services circulars”

Travel vaccines: (in line with NHSE Guidance on items which should not be routinely prescribed in primary Care) This is a restatement of existing regulations and no changes have been made as a result of this guidance

The following vaccines may be administered on the NHS for the purposes of travel, if clinically appropriate: 

  • Cholera
  • Diphtheria/ Tetanus/ Polio
  • Hepatitis A
  • Typhoid

The following vaccines should not be prescribed on the NHS exclusively for the purposes of travel, but may be prescribed on the NHS for all other indications listed in Immunisation Against Infectious Disease (The Green Book)

  • Hepatitis B
  • Japanese encephalitis
  • Meningitis ACWY
  • Yellow Fever
  • Tick-borne encephalitis
  • Rabies
  • BCG

These vaccines should continue to be recommended for travel, but the individual traveller will need to bear the cost of the vaccination.

Patient Information Leaflet

14.05  Expand sub section  Immunoglobulins
14.05  Expand sub section  Normal immunoglobulin
14.05  Expand sub section  Specific immunoglobulins
14.05  Expand sub section  Anti-D (Rho) immunoglobulin
14.05  Expand sub section  Interferons to top
14.05.01  Expand sub section  Normal immunoglobulin
14.05.02  Expand sub section  Disease-specific immunoglobulins
14.05.03  Expand sub section  Anti-D (Rho) immunoglobulin
 Non Formulary Items

View adult BNF View SPC online View childrens BNF
Non Formulary
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Track Changes
Display tracking information
click to search
Link to adult BNF
click to search
Link to children's BNF
click to search
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHS England

Traffic Light Status Information

Status Description

Prescribing in children

The APC notes that the informed use of unlicensed medicines or of licensed medicines for unlicensed applications (‘off-label’ use) is often necessary in paediatric practice.

The APC advises GPs to consider specialist prescribing recommendations for Green and Amber medicines that are not subject to ESCAs or RICaDs in combination with the information provided in the BNFC which goes beyond that of marketing authorisations. The BNFC has been designed for rapid reference and the information presented has been carefully selected to aid decisions on prescribing.



Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications.  


Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate, or initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.

Some amber medicines require agreement with the local (internal) medicines committee prior to initiation; others may require a framework to support safe transfer and maintenance of care such as a RICaD or ESCA. The Formulary will be annotated to reflect these requirements.   


Medicines for initiation and maintenance prescribing by Specialists only  


Non-formulary medicines- medicines not recommended for routine primary care prescribing.  


Positive NICE TA and /or awaiting local clarification on place in therapy ; Please contact your Medicines Optimisation team for more information.